| 16 |
Nanobody library screening 문의 |
2025.05.28 |
Complete |
|
└ Re : Nanobody library screening 문의 |
2025.06.05 |
Accepting |
| 14 |
Company Introduction and Development Pipeline Overview |
2025.03.11 |
Complete |
|
└ Re : Company Introduction and Development Pipeline Overview |
2025.03.17 |
Accepting |
| 12 |
recombinant protein 관련 문의드립니다. |
2024.01.18 |
Complete |
|
└ Re : recombinant protein 관련 문의드립니다. |
2024.01.29 |
Accepting |
| 10 |
product interest |
2023.11.30 |
Accepting |
| 9 |
scFv 선별 및 최적화 |
2023.11.27 |
Complete |
|
└ Re : scFv 선별 및 최적화 |
2023.11.29 |
Accepting |
| 7 |
Hybridoma sequencing and Recombinant antibody expression |
2023.09.12 |
Accepting |
| 6 |
Hybridoma order |
2023.07.04 |
Complete |
|
└ Re : Hybridoma order |
2023.07.13 |
Accepting |
| 4 |
affinity maturation service estimate |
2023.05.24 |
Complete |
|
└ Re : affinity maturation service estimate |
2023.05.26 |
Accepting |
| 2 |
NK Cell Engaging Bispecific Antibodies |
2023.05.15 |
Complete |
|
└ Re : NK Cell Engaging Bispecific Antibodies |
2023.05.16 |
Accepting |
